1.

Emrani S, Lamar M, Price CC, Wasserman V, Matusz E, Au R, Swenson R, Nagele R, Heilman KM, Libon DJ. Alzheimer's/Vascular Spectrum Dementia: Classification in Addition to Diagnosis. J Alzheimers Dis. 2020;73(1):63-71. [PubMed]

2.

Legdeur N, van der Lee SJ, de Wilde M, van der Lei J, Muller M, Maier AB, Visser PJ. The association of vascular disorders with incident dementia in different age groups. Alzheimers Res Ther. 2019 May 17;11(1):47. [PMC free article] [PubMed]

3.

Chan KY, Wang W, Wu JJ, Liu L, Theodoratou E, Car J, Middleton L, Russ TC, Deary IJ, Campbell H, Wang W, Rudan I., Global Health Epidemiology Reference Group (GHERG). Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet. 2013 Jun 08;381(9882):2016-23. [PubMed]

4.

Forrest SL, Kovacs GG. Current Concepts of Mixed Pathologies in Neurodegenerative Diseases. Can J Neurol Sci. 2023 May;50(3):329-345. [PubMed]

5.

Lamar M, Leurgans S, Kapasi A, Barnes LL, Boyle PA, Bennett DA, Arfanakis K, Schneider JA. Complex Profiles of Cerebrovascular Disease Pathologies in the Aging Brain and Their Relationship With Cognitive Decline. Stroke. 2022 Jan;53(1):218-227. [PMC free article] [PubMed]

6.

Balls-Berry JJE, Babulal GM. Health Disparities in Dementia. Continuum (Minneap Minn). 2022 Jun 01;28(3):872-884. [PMC free article] [PubMed]

7.

Schultz SK, Llorente MD, Sanders AE, Tai WA, Bennett A, Shugarman S, Roca R. Quality improvement in dementia care: Dementia Management Quality Measurement Set 2018 Implementation Update. Neurology. 2020 Feb 04;94(5):210-216. [PubMed]

8.

Charles CV. 2023 AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older People: A Summary of the Updates. Sr Care Pharm. 2023 Sep 01;38(9):352-354. [PubMed]

9.

Bennett S, Thomas AJ. Depression and dementia: cause, consequence or coincidence? Maturitas. 2014 Oct;79(2):184-90. [PubMed]

10.

Fieo RA, Austin EJ, Starr JM, Deary IJ. Calibrating ADL-IADL scales to improve measurement accuracy and to extend the disability construct into the preclinical range: a systematic review. BMC Geriatr. 2011 Aug 16;11:42. [PMC free article] [PubMed]

11.

Skrobot OA, O'Brien J, Black S, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I, VICCCS group. Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG. The Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement. 2017 Jun;13(6):624-633. [PubMed]

12.

Chang Wong E, Chang Chui H. Vascular Cognitive Impairment and Dementia. Continuum (Minneap Minn). 2022 Jun 01;28(3):750-780. [PMC free article] [PubMed]

13.

Calabrese P, Sitek EJ, Korczyn AD, Dong Y, Manso-Calderón R, Sierra-Beltrán M, Skrzypkowska A, Stefanova E. The assessment of cognitive and behavioural disturbances in vascular cognitive impairment (VCI) - recommendations of an expert working group. Neurol Neurochir Pol. 2021;55(4):333-345. [PubMed]

14.

Pan FF, Huang L, Chen KL, Zhao QH, Guo QH. A comparative study on the validations of three cognitive screening tests in identifying subtle cognitive decline. BMC Neurol. 2020 Mar 05;20(1):78. [PMC free article] [PubMed]

15.

Song Y, Quan M, Li T, Jia J. Serum Homocysteine, Vitamin B12, Folate, and Their Association with Mild Cognitive Impairment and Subtypes of Dementia. J Alzheimers Dis. 2022;90(2):681-691. [PubMed]

16.

Roberts RO, Knopman DS, Przybelski SA, Mielke MM, Kantarci K, Preboske GM, Senjem ML, Pankratz VS, Geda YE, Boeve BF, Ivnik RJ, Rocca WA, Petersen RC, Jack CR. Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology. 2014 Apr 01;82(13):1132-41. [PMC free article] [PubMed]

17.

Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987 Aug;149(2):351-6. [PubMed]

18.

Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, Langhorne P, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Pantoni L., LADIS Study Group. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ. 2009 Jul 06;339:b2477. [PMC free article] [PubMed]

19.

Cummings J. The Neuropsychiatric Inventory: Development and Applications. J Geriatr Psychiatry Neurol. 2020 Mar;33(2):73-84. [PMC free article] [PubMed]

20.

Custodero C, Ciavarella A, Panza F, Gnocchi D, Lenato GM, Lee J, Mazzocca A, Sabbà C, Solfrizzi V. Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis. Geroscience. 2022 Jun;44(3):1373-1392. [PMC free article] [PubMed]

21.

Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC, Virani SS, Williams KA, Yeboah J, Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10;140(11):e596-e646. [PMC free article] [PubMed]

22.

Peters R, Yasar S, Anderson CS, Andrews S, Antikainen R, Arima H, Beckett N, Beer JC, Bertens AS, Booth A, van Boxtel M, Brayne C, Brodaty H, Carlson MC, Chalmers J, Corrada M, DeKosky S, Derby C, Dixon RA, Forette F, Ganguli M, van Gool WA, Guaita A, Hever AM, Hogan DB, Jagger C, Katz M, Kawas C, Kehoe PG, Keinanen-Kiukaanniemi S, Kenny RA, Köhler S, Kunutsor SK, Laukkanen J, Maxwell C, McFall GP, van Middelaar T, Moll van Charante EP, Ng TP, Peters J, Rawtaer I, Richard E, Rockwood K, Rydén L, Sachdev PS, Skoog I, Skoog J, Staessen JA, Stephan BCM, Sebert S, Thijs L, Trompet S, Tully PJ, Tzourio C, Vaccaro R, Vaaramo E, Walsh E, Warwick J, Anstey KJ. Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis. Neurology. 2020 Jan 21;94(3):e267-e281. [PMC free article] [PubMed]

23.

Hua R, Ma Y, Li C, Zhong B, Xie W. Low levels of low-density lipoprotein cholesterol and cognitive decline. Sci Bull (Beijing). 2021 Aug 30;66(16):1684-1690. [PubMed]

24.

Cheon DY, Han KD, Kim CH, Oh MS, Lee BC, Kim Y, Lee SH, Kim C, Lim JS, Lee M, Yu KH. Association between exercise habit changes and incident dementia after ischemic stroke. Sci Rep. 2023 Mar 09;13(1):3959. [PMC free article] [PubMed]

25.

Gómez-Gómez ME, Zapico SC. Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions. Int J Mol Sci. 2019 Jun 11;20(11) [PMC free article] [PubMed]

26.

Jiménez-Pavón D, Carbonell-Baeza A, Lavie CJ. Promoting the Assessment of Physical Activity and Cardiorespiratory Fitness in Assessing the Role of Vascular Risk on Cognitive Decline in Older Adults. Front Physiol. 2019;10:670. [PMC free article] [PubMed]

27.

Cummings J, Aisen P, Apostolova LG, Atri A, Salloway S, Weiner M. Aducanumab: Appropriate Use Recommendations. J Prev Alzheimers Dis. 2021;8(4):398-410. [PMC free article] [PubMed]

28.

van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T. Lecanemab in Early Alzheimer's Disease. N Engl J Med. 2023 Jan 05;388(1):9-21. [PubMed]

29.

Mitchell SL, Teno JM, Kiely DK, Shaffer ML, Jones RN, Prigerson HG, Volicer L, Givens JL, Hamel MB. The clinical course of advanced dementia. N Engl J Med. 2009 Oct 15;361(16):1529-38. [PMC free article] [PubMed]

30.

Kua EH, Ho E, Tan HH, Tsoi C, Thng C, Mahendran R. The natural history of dementia. Psychogeriatrics. 2014 Sep;14(3):196-201. [PubMed]

31.

Staekenborg SS, Pijnenburg YA, Lemstra AW, Scheltens P, Vd Flier WM. Dementia and Rapid Mortality: Who is at Risk? J Alzheimers Dis. 2016 Apr 19;53(1):135-42. [PubMed]

32.

Grand JH, Caspar S, Macdonald SW. Clinical features and multidisciplinary approaches to dementia care. J Multidiscip Healthc. 2011;4:125-47. [PMC free article] [PubMed]

33.

Pantoni L, Poggesi A, Diciotti S, Valenti R, Orsolini S, Della Rocca E, Inzitari D, Mascalchi M, Salvadori E. Effect of Attention Training in Mild Cognitive Impairment Patients with Subcortical Vascular Changes: The RehAtt Study. J Alzheimers Dis. 2017;60(2):615-624. [PMC free article] [PubMed]

34.

O'Neill D. Practice Parameter update: Evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010 Nov 02;75(18):1659; author reply 1659-60. [PubMed]

35.

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimäki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbæk G, Teri L, Mukadam N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020 Aug 08;396(10248):413-446. [PMC free article] [PubMed]

36.

Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005 Jan 25;64(2):277-81. [PubMed]

37.

Ritter A, Pillai JA. Treatment of Vascular Cognitive Impairment. Curr Treat Options Neurol. 2015 Aug;17(8):367. [PubMed]